XML 73 R46.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Effective Income Tax Rate Reconciliation

A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

 

 

Year Ended December 31,

 

 

 

 

2024

 

 

 

2023

 

 

Federal statutory income tax rate

 

 

21.0

 

%

 

 

21.0

 

%

State income tax, net of federal benefit

 

 

1.5

 

%

 

 

2.2

 

%

Federal and state research and development
   tax credits

 

 

2.9

 

%

 

 

2.1

 

%

Change in fair value of warrant liabilities

 

 

(5.1

)

%

 

 

(4.8

)

%

Stock-based compensation

 

 

(2.1

)

%

 

 

(1.1

)

%

Non-deductible items

 

 

(0.4

)

%

 

 

(0.1

)

%

State rate change

 

 

(0.5

)

%

 

 

1.3

 

%

Uncertain tax positions

 

 

(0.6

)

%

 

 

(2.2

)

%

Other

 

 

 

%

 

 

0.4

 

%

Change in deferred tax asset valuation
   allowance

 

 

(16.7

)

%

 

 

(18.8

)

%

Effective income tax rate

 

 

0.0

 

%

 

 

0.0

 

%

Schedule of Net Deferred Tax Assets

The Company’s net deferred tax assets consisted of the following:

 

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Deferred tax assets:

 

 

 

 

 

 

NOL carryforwards

 

$

39,470

 

 

$

35,419

 

Capitalized research and development
   expenditures

 

 

10,728

 

 

 

8,281

 

Research and development tax credit
   carryforwards

 

 

5,425

 

 

 

4,148

 

Stock-based compensation

 

 

2,892

 

 

 

2,735

 

Operating lease liabilities

 

 

1,687

 

 

 

1,007

 

Accruals and other temporary differences

 

 

2,429

 

 

 

1,256

 

Total deferred tax assets

 

 

62,631

 

 

 

52,846

 

Valuation allowance

 

 

(61,023

)

 

 

(51,903

)

Deferred tax assets

 

 

1,608

 

 

 

943

 

 

 

 

 

 

 

 

Deferred tax liabilities:

 

 

 

 

 

 

Operating lease right-of-use asset

 

 

(1,545

)

 

 

(888

)

Other

 

 

(63

)

 

 

(55

)

Total deferred tax liabilities

 

 

(1,608

)

 

 

(943

)

Net deferred tax assets

 

$

 

 

$

 

Schedule of Changes in Valuation Allowance for Deferred Tax Assets

Changes in the valuation allowance for deferred tax assets related primarily to the increase in NOL carryforwards and research and development tax credit carryforwards and were as follows:

 

 

 

Year Ended December 31,

 

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Valuation allowance as of beginning of year

 

$

51,903

 

 

$

43,632

 

Increases

 

 

9,120

 

 

 

8,271

 

Valuation allowance as of end of year

 

$

61,023

 

 

$

51,903

 

Schedule of Changes in Unrecognized Tax Benefits

The changes in the Company’s unrecognized tax benefits are summarized as follows:

 

 

 

December 31,

 

 

 

2024

 

 

2023

 

 

 

(in thousands)

 

Beginning balance

 

$

1,053

 

 

$

 

Increases related to prior year tax positions

 

 

 

 

 

854

 

Increases related to current year tax positions

 

 

348

 

 

 

199

 

Ending balance

 

$

1,401

 

 

$

1,053